FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmed’s ALIS for the Treatment of NTM Lung Disease Caused by MAC for Adult Patients with Limited or No Treatment Options
medical device investing Wright Medical Announces FDA Premarket Approval for AUGMENT Injectable Bone Graft
